New Companies

Found 3,666 articles

• Almirall launches its second innovation initiative for dermatology-focused digital health start-ups

  10/16/2020

  Almirall, S.A. (ALM ) has launched its second innovation challenge open to worldwide startups who can disrupt the future of digital health. Start-ups can apply between now and October 31 at almiralldigitalgarden.com for a chance to participate in the nine-month accelerator program Digital Garden , powered by Almirall

• Growing Global Demand for ESP Disc Replacements Leads to Formation of Independent Company -- Spine Innovations to Launch October 1

  9/30/2020

  The growing global demand for ESP disc replacements has led to the creation of an independent company called Spine Innovations, scheduled to launch on October 1, 2020.

• Aptorum Group Launches Infectious Disease Liquid Biopsy Subsidiary Start-up and Exclusively In-licensed from Singapore based Accelerate Technologies To Co-Develop Molecular Based Rapid Pathogen Diagnostics Technology To Track Pathogenic Genome

  9/29/2020

  Aptorum Group Limited announced its launch of Aptorum Innovations - an infectious disease liquid biopsy diagnostics subsidiary and its newly established exclusive in-licensing arrangements with Accelerate Technologies Pte Ltd

• Flagship Pioneering Announces Valo Health to Transform Drug Development

  9/24/2020

   Flagship Pioneering today announced the launch of Valo Health, LLC (Valo), a drug discovery technology company setting out to transform how oncology, neurodegenerative, and cardiovascular disease drugs are created, developed, and approved.

• Cullinan Oncology, German Cancer Research Center (DKFZ) and the University of Tübingen Announce the Formation of Cullinan Florentine to Develop CLN-049, a Novel Bispecific Antibody for AML

  9/15/2020

  Cullinan Oncology, LLC, the German Cancer Research Center and the Eberhard Karls University of Tübingen, Faculty of Medicine (University of Tübingen), Germany, today announced the formation of Cullinan Florentine, a company focused on developing a novel FLT3 x CD3 bispecific antibody for the treatment of patients with acute myeloid leukemia (AML). This antibody has been developed in Tübingen wit

• GlycoT Therapeutics Grants Sublicense of Glycoengineering Technology to Daiichi Sankyo

  9/14/2020

   GlycoT Therapeutics LLC, a UM Ventures start-up company based on intellectual property (IP) developed at the University of Maryland, Baltimore (UMB) and University of Maryland, College Park (UMCP), has executed a sublicense agreement for its glycoengineering technology with Daiichi Sankyo Company, Limited (Daiichi Sankyo; www.da

• 

  ATAI Life Sciences Launches EmpathBio with Focus on PTSD Treatment

  8/25/2020

  ATAI Life Sciences announced on Monday that it has launched EmpathBio, a wholly-owned subsidiary focused on developing derivatives of 3,4-methylenedioxy-methamphetamine (MDMA) for the treatment of post-traumatic stress disorder.

• Rafarma Establishes Thailand Corporate Entity For Merger and Expansion Projects

  8/25/2020

  Rafarma Pharmaceuticals, Inc. “OTC:” is pleased to announce that it has established a new corporate entity in Thailand.

• Biotechnology Company Hopes to Cure Hemophilia with Gene Editing

  8/25/2020

  Fixx Pharmaceuticals Inc is a new biotechnology company launching on September 1, 2020.

• Cannformatics Receives Approval For Pilot Study Identifying Cannabis-Responsive™ Biomarkers In Children With Autism

  8/19/2020

  Cannformatics , an early stage biotech startup focused on personalizing medical cannabis treatments through the identification and application of cannabis - responsive ™ biomarkers found

• Connecticut Biotech Launches New 3D Printed Mask Frame

  8/14/2020

  Connecticut Biotech, a new innovative start-up company, is announcing the launch of its Secure Fit 3D-printed face mask frame. The mask frames are an exoskeleton worn outside of a traditional surgical mask, providing enhanced efficacy in protection against COVID-19 and other airborne pathogens. Secure Fit is a reusable, re

• BioUtah Statement on Launch of Altitude Lab, Largest Life Sciences Incubator in Utah

  8/12/2020

  Recursion and University of Utah found incubator to propel new generation of life sciences in the region

• Ontera spins out Nooma Bio, Inc.

  8/10/2020

  Ontera, Inc., the leader in silicon-based nanopore sensing and diagnostics, is taking another step toward realizing its mission of providing better biological information for a healthier planet; this time, by spinning out a new company, Nooma Bio, Inc. (Nooma).

• Versant Ventures Launches Matterhorn Biosciences

  8/5/2020

  Versant Ventures today announced the debut of Matterhorn Biosciences AG, a biotechnology company developing T cell receptor therapies based on the recent discovery of MR1T cells that

• Versant Ventures Launches Bright Peak Therapeutics

  7/28/2020

  July 28, 2020 12:00 UTC --Next-wave engineered protein company with pipeline of cytokine therapeutics developed in Versant’s Ridgeline Discovery Engine-- --First IL-2 development candidate shows superior properties to all known competitors-- --Industry veteran Sef Kurstjens joins as president and CEO--

• Company Profile for Venock Inc

  7/28/2020

  Venock Inc is US MedTech company with headquarters in New York City and operations in Munich, Germany.

• National Trauma Institute Restructures as Coalition for National Trauma Research

  7/27/2020

  After serving as the administrative support behind the Coalition for National Trauma Research since its founding in 2014, the National Trauma Institute has officially reorganized as CNTR.

• ATAI launches Viridia Life Sciences to develop novel formulations of N, N-Dimethyltryptamine (DMT) for a range of mental health conditions

  7/22/2020

  Today, ATAI Life Sciences ("ATAI" or the "Company"), a global biotech developing psychedelic and non-psychedelic compounds for a variety of mental health indications, announced the launch of Viridia Life Sciences, a wholly-owned subsidiary developing novel formulations of N,N-Dimethyltryptamine (DMT) to treat a variety of mental health disorders.

• T3 Pharma raises 25M CHF to advance bacterial cancer therapy through clinic

  7/22/2020

  T3 Pharmaceuticals AG announced the closing of its third financing round, raising over 25M CHF.

• Viatris Reveals Branding to Reflect New Company's Transformative Strategy

  7/9/2020

  Announcement follows Mylan shareholder approval of Mylan's combination with Pfizer's Upjohn